Doctor profile · Federal record
Dr. MICHAEL ESCANO, MD
Cardiovascular Disease Physician (CMS: CARDIOVASCULAR DISEASE (CARDIOLOGY)) · MANASSAS, VA
- NPI 1336129147
- Accepts Medicare
- 27 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
8569 SUDLEY RD
MANASSAS, VA 201103863
(703) 369-5959
Credentials & registration
- NPI registered
- January 2006 — 20 yrs on file
- Profile last updated
- April 21, 2023
- Year of graduation
- 1999 — 27 yrs since
- Specialty taxonomy
- 207RC0000X — NUCC code
- State license (1)
- Virginia #0101238319
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1336129147. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,416
Distinct HCPCS
10
Medicare allowed
$303,703
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
93010 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,278 | 990 | $8 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,017 | 604 | $126 | |
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 455 | 436 | $14 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 257 | 251 | $196 | |
J2785 |
Injection, regadenoson, 0.1 mg | 196 | 49 | $52 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 145 | 143 | $68 | |
A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose | 107 | 54 | $116 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 104 | 68 | $78 | |
93793 |
Anticoagulant management of patient taking warfarin | 86 | 48 | $11 | |
93294 |
Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 82 | 46 | $30 |
In context: peer comparison
Among 8 peers in this city , average services per provider: 169. This provider delivers 26× the peer median.Open Payments
Industry payments received
All-time total
$20
Transactions
1
Manufacturers
1
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 1 | $19.94 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,095
Patients
651
Total drug cost
$540,089
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 280 | 79 | $386,530 |
| Metoprolol Succinate | Generic | 277 | 91 | $4,770 |
| Carvedilol | Generic | 239 | 72 | $2,356 |
| Amlodipine Besylate | Generic | 181 | 56 | $1,476 |
| Lisinopril | Generic | 165 | 51 | $1,245 |
| Furosemide | Generic | 140 | 51 | $939 |
| Atorvastatin Calcium | Generic | 132 | 39 | $1,450 |
| Metoprolol Tartrate | Generic | 122 | 38 | $1,025 |
| Losartan Potassium | Generic | 105 | 30 | $1,530 |
| Isosorbide Mononitrate Er (Isosorbide Mononitrate) | Brand | 100 | 32 | $1,797 |